MeTA in Uganda


Published on

Presentation on the background to MeTA initiative in Uganda and the shape of MeTA Uganda.

1 Like
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

MeTA in Uganda

  1. 1. CSO Workshop Sunset Hotel 26 April 2009 Medicines Transparency Alliance (MeTA) Uganda
  2. 2. Presentation Overview  Background to MeTA initiative in Uganda o Sequence of events and consultations o Stakeholder perspectives on MeTA priorities for improved access to medicines  The shape of MeTA in Uganda o Structures: Council, Secretariat, Fund holder o MoU and Work plan Mar-09MeTA Uganda Briefing2
  3. 3. Brief History of MeTA Uganda (2007- 2008)  Scoping study & supply chain study in 2007  MOH accept invitation to join as a MeTA pilot country  CSO members attended capacity building workshop in Uganda (Feb. 2008)  Multi-stakeholder attendance from Uganda at global launch (May 2008)  Int’l Secretariat visit (Oct. 2008)  Short-term TA contracted to support pre-launch processes  Private sector mapping by Int’l consultant (Dec. 2008) Mar-09 3
  4. 4.  Need for info on medicines market / demand – Most stakeholders agree on info sharing, disclosure  Pricing policy, e.g. recomm. / max. retail price – Agreement in the case of essential medicines; lower price=higher access= increased sales  Import of generics vs local manufacture – S/Hs differ on strategic value of local manuf; GI conditionalities = better quality or barrier? Perspectives – Private Sector Mar-09 4
  5. 5.  Transparency in the supply chain – Procurement and supply management information in the public domain  CSO representation at all levels – Enhanced accountability; reduced pilferage  Capacity building for effectiveness – Players in supply chain, n.b. health facility level – CSO participation from policy level to community Perspectives – Civil Society Mar-09 5
  6. 6.  Poor medicines availability in public facilities  Under funding of medicines – 30% of the requirement for UNMHCP; escalating cost due to scale up of programmes needing expensive medicines (ARVs, ITNs, ACTs)  Weak proc. and supply management systems – At all levels; concerns over VFM/ quality in local private sector purchases/ excessive retail mark-ups; reports of leakage Perspectives – Government Mar-09 6
  7. 7. Lead up to Launch (2009)  Formal establishment of National Multi- Stakeholder Council  National MeTA Secretariat streamlined and Coordinator recruited  Fund-holder arrangement  MoU signed for implementation of country work plan Mar-09 7
  8. 8. Activity Stakeholders Periodic surveys of medicines prices and availability MoH, CSOs, WHO Web-based information on registration, quality, volumes and FOB cost of medicines NDA, PS (Manuf/Importers) Evaluation of the rolling plan for provision of medicines for the UNMCHP (FY 08-09) Gov, Dev. Partners, Implem Agencies, TWG Outputs – transparency and information disclosure Mar-09 8
  9. 9. Activity Stakeholders Stop the stock-outs campaign CSOs Multi-stakeholder follow-up of recommendations of the tracking study, periodic surveys and performance evaluation Gov, CS, TWG Outputs – accountability and good governance Mar-09 9
  10. 10. Activity Stakeholders Pilot awareness campaign on approp. use of medicines in communities and train drug handlers CSOs, PSU Contribute to IEC strategies and messages at national level Multi-stakeholder Radio talk shows, jingles Multi-stakeholder Outputs – IEC & awareness Mar-09 10
  11. 11. Activity Stakeholders Build capacity in at least 30 CSOs to effectively participate in improved governance, transparency and accountability in medicines supply chain Expanded CS-MeTA alliance Engage policy makers on the issue of low availability / high stock-outs of medicines MoH, MoFPED, LG, Parliament, AG, PPDA, NDA, NMS Outputs – CSO capacity building Mar-09 11
  12. 12. Summary - MeTA  Global initiative to improve access to medicines through increased transparency & accountability  Governed by national & international multi- stakeholder forums  Progressive disclosure of data collected / information reported = key outcome of pilot Mar-09 12
  13. 13. Thank you! Questions, comments …???? More about MeTA: Mar-09MeTA Uganda Launch13